Cargando…
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays
BACKGROUND: December 2021 witnessed an unprecedented increase in SARS-CoV-2 infections in addition to the circulation of influenza A and respiratory syncytial viruses (RSV). Due to increased testing demands for SARS-CoV-2, influenza, and RSV associated with the overall increase in symptomatic respir...
Autores principales: | Quinton, Mikayla, Geahr, Melissa, Gluck, Linda, Jarrett, Junko, Mostafa, Heba H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014635/ https://www.ncbi.nlm.nih.gov/pubmed/35468544 http://dx.doi.org/10.1016/j.jcv.2022.105164 |
Ejemplares similares
-
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
por: Meletis, Georgios, et al.
Publicado: (2022) -
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test
por: Mostafa, Heba H., et al.
Publicado: (2020) -
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
por: Heideman, Daniëlle A. M., et al.
Publicado: (2022) -
Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load
por: Chooramani, Gagan, et al.
Publicado: (2023) -
Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assays
por: Ehret, Robert, et al.
Publicado: (2022)